Show simple item record

dc.contributor.authorHollen, Patricia J.en_US
dc.contributor.authorGralla, Richard J.en_US
dc.contributor.authorKris, Mark G.en_US
dc.date.accessioned2011-10-13T18:46:42Zen_US
dc.date.accessioned2012-02-13T19:26:56Z
dc.date.available2011-10-13T18:46:42Zen_US
dc.date.available2012-02-13T19:26:56Z
dc.date.issued2004en_US
dc.identifier.urihttp://hdl.handle.net/10477/1909
dc.descriptionLCSS evaluates six major symptoms associated with lung malignancies and their effect on overall symptomatic distress, functional activities, and global QL. The philosophy behind the development of the LCSS is to provide a practical QL measure that reduces patient and staff burden in serial measurement of QL during the course of the trial. It captures in detail those dimensions most likely to be influenced by therapeutic interventions and evaluates other dimensions globally. It consists of two scales: one completed by the patient and an optional one for health care professionals ("counterpart observer") to provide context.en_US
dc.description.abstractThe LCSS is designed as a site-specific measure of quality of life (QL), particularly for use in clinical trials.en_US
dc.language.isoen_USen_US
dc.subjectLung Cancer Symptom Scale (LCSS)en_US
dc.subjectLCSSen_US
dc.subjectLung Canceren_US
dc.titleLung Cancer Symptom Scale (LCSS)en_US
dc.typeOtheren_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record